Market Overview

UPDATE: Stifel Nicolaus Initiates Medtronic at Hold on Valuation

Share:
Related MDT
SkyTides: Insulet's President Provided 'Critical Misinformation To Investors'
10 Stocks With Lowest Close In Three Weeks
What Happened To Medtronic's Free Cash Flow Story? (Seeking Alpha)

Stifel Nicolaus initiated coverage on Medtronic (NYSE: MDT) with a Hold rating.

Stifel Nicolaus commented, "We are initiating coverage of Medtronic, Inc. (MDT) with a Hold rating on the shares. Fair-to-reasonable valuation for the stock and lack of dramatic upside drivers keep us on the sidelines for the moment. With approximately 50% of Medtronic's business still in pressured "no growth" markets (Cardiac Rhythm Management and Spine) and limited room for further operating margin expansion, we suspect Medtronic's 10.8x forward P/E multiple is unlikely to expand significantly on a relative basis. With MDT shares already trading at the high end of the industry peer group on an EV/EBITDA basis, we prefer to wait for a better entry point on the shares."

Medtronic closed at $41.10 on Monday.

Latest Ratings for MDT

DateFirmActionFromTo
Nov 2016BarclaysMaintainsOverweight
Nov 2016BMO CapitalMaintainsOutperform
Nov 2016JefferiesMaintainsBuy

View More Analyst Ratings for MDT
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (MDT)

View Comments and Join the Discussion!